Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization

PURPOSE: Anti-VEGF resistance represents a major unmet clinical need in the management of choroidal neovascularization (CNV). We have previously reported that a combination of AIBP, apoA-I, and an anti-VEGF antibody overcomes anti-VEGF resistance in laser-induced CNV in old mice in prevention experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhao, Shen, Megan M., Fu, Yingbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Biochemistry and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639697/
https://www.ncbi.nlm.nih.gov/pubmed/36318195
http://dx.doi.org/10.1167/iovs.63.12.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639697/
https://www.ncbi.nlm.nih.gov/pubmed/36318195
http://dx.doi.org/10.1167/iovs.63.12.2

Ejemplares similares